| Name | HS-27 |
|---|
| Description | Hs-27 is a Novel Hsp90 Inhibitor, Exhibits Diagnostic and Therapeutic Potential in Triple Negative Breast Cancer. |
|---|---|
| Related Catalog | |
| Target |
HSP90 |
| In Vitro | HS-27 labels all receptor subtypes of breast cancer, but not normal cells, and specifically binds to Hsp90 expressed on the surface of breast cancer cells before being internalized. HS-27 fluorescence is greater in tumor than non-tumor tissue[1]. |
| References |
| Molecular Formula | C52H60N6O12S |
|---|---|
| Molecular Weight | 992.4 |